FDA Takes “Fresh Look” At ORA Reorg, Eyes Outsourcing Some Agency Posts
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Regulatory Affairs still plans to reorganize, despite its recent decision to cancel the planned closure of seven field labs
You may also be interested in...
FDA Office Of Regulatory Affairs Make-Over Blends Domestic, International Work
The reorganized ORA has eight new offices to better handle new legislative authorities and globalization of its regulated products; FDA expects to increase partnerships with other government officials and foreign entities.
FDA’s Office Of Regulatory Affairs Loses Two Top Officials, Including Chief
The face of FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing the agency's inspections and enforcement activity
FDA’s Office Of Regulatory Affairs Loses Two Top Officials, Including Chief
The face of FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing the agency's inspections and enforcement activity